Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors.

0.6, p =0.005) and remained nominally significant in the NHW group (AF=0.33 vs. 0.6, p =0.02) (Supplemental Table S9, http://links.lww.com/HC9/B26 ).

also in 7,732 other papers

Although rs34234515 in SLCO1B1 is impacted by concomitant statin exposure, this variant did not reach statistical significance in those with and without statin exposure ( p =0.33 and 0.32) (Supplemental Table S8, http://links.lww.com/HC9/B26 ).

also in 111,027 other papers